HEARING
Legislative Hearing on Discussion Drafts Concerning Prescription Drug User Fee Act Reauthorization, Medical Device User Fee and Modernization Act Reauthorization, Drug Safety, and Certain Pediatric Pharmaceutical and Device Legislation
Subcommittee on Health
Tuesday, June 12, 2007, 10:00 a.m.
2123 Rayburn House Office Building
Hearing Webcast
(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)
Connect to the Archived Video Webcast of this Hearing (100 kbps) or Download
Windows Media Player is required for Committee Webcasts.
Witness List & Prepared Testimony (pdf files)
| Panel I |
|
Randall L. Lutter, Ph.D.
Associate Commissioner for Policy and Planning
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
|
|
| Panel II |
|
Richard L. Gorman, M.D., F.A.A.P.
Chair
AAP Section on Clinical Pharmacology and Therapeutics
American Academy of Pediatrics
601 Thirteenth Street, NW, Suite 400
Washington, DC 20005
|
Diana Zuckerman, Ph.D.
President
National Research Center for Women & Families
1701 K Street, NW, Suite 700
Washington, DC 20006 |
Caroline Loew, Ph.D.
Senior Vice President
Science and Regulatory Affairs
PhRMA
950 F Street, NW
Washington, DC 20004
|
Mr. Steve Walker
Co-Founder and Chief Advisor
Abigail Alliance for Better Access to Developmental Drugs
36 Aspen Hill Drive
Fredericksburg, VA 22406 |
Mr. James Guest
President and CEO
Consumers Union
101 Truman Avenue
Yonkers, NY 10703
|
Mr. Steven J. Ubl
President and CEO
Advanced Medical Technology Association
701 Pennsylvania Avenue, NW, Suite 800
Washington, DC 20004 |
Hearing Transcript
Not available at this time. The printed hearing should be available within 90-120 days of the conclusion of the hearing. When available, the text of the printed hearing may be viewed at the U.S. Government Printing Office Web site.
|
